Severe myopathy in a patient with chronic neurological disease – diagnostic challenges

Polymyositis is a rare disease that belongs to the idiopathic inflammatory myopathies (IIMs) group, characterized by chronic muscle inflammation, and in rare cases a life-threatening condition due to extra-muscular involvement. Even though steroids constitute the building block of treatment of this...

Full description

Bibliographic Details
Main Authors: Cristian-Mihai Ilie, Suzana Popescu, Sinziana Daia-Iliescu, Ioana Saulescu, Denisa Predeteanu, Violeta-Claudia Bojinca, Andra Balanescu, Daniela Opris-Belinski
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2023-06-01
Series:Romanian Journal of Rheumatology
Subjects:
Online Access:https://rjr.com.ro/articles/2023.2/RJR_2023_2_Art-02.pdf
_version_ 1827576811607818240
author Cristian-Mihai Ilie
Suzana Popescu
Sinziana Daia-Iliescu
Ioana Saulescu
Denisa Predeteanu
Violeta-Claudia Bojinca
Andra Balanescu
Daniela Opris-Belinski
author_facet Cristian-Mihai Ilie
Suzana Popescu
Sinziana Daia-Iliescu
Ioana Saulescu
Denisa Predeteanu
Violeta-Claudia Bojinca
Andra Balanescu
Daniela Opris-Belinski
author_sort Cristian-Mihai Ilie
collection DOAJ
description Polymyositis is a rare disease that belongs to the idiopathic inflammatory myopathies (IIMs) group, characterized by chronic muscle inflammation, and in rare cases a life-threatening condition due to extra-muscular involvement. Even though steroids constitute the building block of treatment of this disease, in severe cases, escalation treatment should be considered in order to obtain good clinical outcomes. We report a clinical case of a 22-year-old female who developed progressive severe systemic muscular weakness, dysphagia and dysphonia, accompanied by elevated serum muscle enzymes, positive myositis-specific antibodies, and muscle biopsy suggestive of inflammatory myopathy. The clinical features and laboratory results led us to the diagnosis of polymyositis. On additional laboratory tests the patient tested positive for Borrelia burgdorferi (Borrelia b) specific antibodies. Due to life-threatening organ involvement the immunosuppressive treatment, immunoglobulin intravenous infusion and pulse therapy with methylprednisolone were initiated and she needed nasogastric tube in order to be fed. Furthermore antibiotic treatment was administrated. The patient improved almost completely after 3 months of treatment.
first_indexed 2024-03-08T21:17:51Z
format Article
id doaj.art-e4fe667c86444927be387eab18f07182
institution Directory Open Access Journal
issn 1843-0791
2069-6086
language English
last_indexed 2024-03-08T21:17:51Z
publishDate 2023-06-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Rheumatology
spelling doaj.art-e4fe667c86444927be387eab18f071822023-12-21T15:21:41ZengAmaltea Medical Publishing HouseRomanian Journal of Rheumatology1843-07912069-60862023-06-01322657110.37897/RJR.2023.2.2Severe myopathy in a patient with chronic neurological disease – diagnostic challengesCristian-Mihai Ilie0Suzana Popescu1Sinziana Daia-Iliescu2Ioana Saulescu3Denisa Predeteanu4Violeta-Claudia Bojinca5Andra Balanescu6Daniela Opris-Belinski7Internal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaInternal Medicine and Rheumatology Department, “Sf. Maria” Clinical Hospital, Bucharest, Romania; Internal Medicine and Rheumatology Department, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaPolymyositis is a rare disease that belongs to the idiopathic inflammatory myopathies (IIMs) group, characterized by chronic muscle inflammation, and in rare cases a life-threatening condition due to extra-muscular involvement. Even though steroids constitute the building block of treatment of this disease, in severe cases, escalation treatment should be considered in order to obtain good clinical outcomes. We report a clinical case of a 22-year-old female who developed progressive severe systemic muscular weakness, dysphagia and dysphonia, accompanied by elevated serum muscle enzymes, positive myositis-specific antibodies, and muscle biopsy suggestive of inflammatory myopathy. The clinical features and laboratory results led us to the diagnosis of polymyositis. On additional laboratory tests the patient tested positive for Borrelia burgdorferi (Borrelia b) specific antibodies. Due to life-threatening organ involvement the immunosuppressive treatment, immunoglobulin intravenous infusion and pulse therapy with methylprednisolone were initiated and she needed nasogastric tube in order to be fed. Furthermore antibiotic treatment was administrated. The patient improved almost completely after 3 months of treatment.https://rjr.com.ro/articles/2023.2/RJR_2023_2_Art-02.pdfpolymyositisimmunosuppressivecyclophosphamide
spellingShingle Cristian-Mihai Ilie
Suzana Popescu
Sinziana Daia-Iliescu
Ioana Saulescu
Denisa Predeteanu
Violeta-Claudia Bojinca
Andra Balanescu
Daniela Opris-Belinski
Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
Romanian Journal of Rheumatology
polymyositis
immunosuppressive
cyclophosphamide
title Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
title_full Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
title_fullStr Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
title_full_unstemmed Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
title_short Severe myopathy in a patient with chronic neurological disease – diagnostic challenges
title_sort severe myopathy in a patient with chronic neurological disease diagnostic challenges
topic polymyositis
immunosuppressive
cyclophosphamide
url https://rjr.com.ro/articles/2023.2/RJR_2023_2_Art-02.pdf
work_keys_str_mv AT cristianmihaiilie severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT suzanapopescu severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT sinzianadaiailiescu severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT ioanasaulescu severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT denisapredeteanu severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT violetaclaudiabojinca severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT andrabalanescu severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges
AT danielaoprisbelinski severemyopathyinapatientwithchronicneurologicaldiseasediagnosticchallenges